Biosynth

VIO Chemicals specializes in providing tailored solutions for various industries, including chemical, pharmaceutical, cosmetics, food, and nutraceuticals. The company focuses on developing chemical processes to enhance product quality and efficiency. Their offerings include a range of non-pharmaceutical intermediates, such as amino acid derivatives, chiral intermediates, and fluorinated aromatics. Additionally, VIO Chemicals produces materials for electronic devices and technologies related to water treatment. By leveraging their expertise in chemical manufacturing, they aim to support businesses in improving their products across multiple sectors.

Celares is a biotechnology company focused on the development of conjugate vaccines and bioconjugate drugs aimed at supporting diagnostic and pharmaceutical companies. The company specializes in the GMP production of bioconjugates and functionalized polymers that serve as excipients in drug formulation. Celares offers a range of customized services, including feasibility studies, up-scaling, and process development, as well as the development and validation of necessary analytical methods. This positions Celares to address the challenges faced by traditional pharmaceutical companies, which often struggle with the flexibility and speed required to develop the technological expertise needed for biopharmaceutical formulation.

Cambridge Research Biochemicals is an independent manufacturer specializing in custom-made peptides and antibodies, catering to the pharmaceutical, life sciences, and academic sectors globally. The company focuses on producing a wide range of peptides, from simple to modified forms, including stable, radio-labeled, and dye-labeled variants, available in milligram to gram-scale quantities with high purity levels. Additionally, Cambridge Research Biochemicals excels in generating target-specific antibodies, which may include various modifications and labeling options. Its products serve essential roles in early-phase drug discovery and support biomarker programs in clinical studies, thereby enhancing research and development efforts in combating diseases.

Fitzgerald Industries International is a manufacturer and supplier of biological reagents located in Acton, Massachusetts. The company specializes in providing primary antibodies, secondary antibodies, recombinant and native proteins, ELISA kits, serum, and plasma. Fitzgerald Industries emphasizes personalized technical support, catering to the specific needs of researchers in various scientific fields. With a team composed of experienced scientists, the company aims to understand and address the challenges faced in laboratory settings. Their commitment to outstanding customer service and high-quality products at competitive prices contributes to their reputation and success in the industry.

EUCODIS Bioscience GmbH is a manufacturer of enzyme solutions that cater to various industries, including biopharma, fine chemicals, and cosmetics. Established in 2007 and based in Vienna, Austria, with a subsidiary in Germany, the company produces a diverse range of enzymes such as lipases, peroxidases, and nitrile hydratases. These enzymes facilitate applications including the stereospecific resolution of chiral alcohols and acids for active pharmaceutical ingredient synthesis, the production of sensitive esters, and the selective hydrolysis of fatty acids. Additionally, EUCODIS offers services in protein and enzyme engineering, bioprocess development, and industrial manufacturing. Their products are utilized by leading companies in the chemical, pharmaceutical, food, and cosmetics sectors to enhance production efficiency and comply with environmental standards.

Pepscan is a biotechnology firm specializing in peptide development and production, leveraging 25 years of expertise in the field. Based in Lelystad, the Netherlands, Pepscan provides a comprehensive suite of services, including peptide synthesis, modifications, high-throughput screening, and the creation of peptide libraries, which are essential for advancing medical research. The company is known for its patented technologies, such as the CLIPS technology that stabilizes peptides in active conformations, and its epitope mapping service, which aids biotech companies in developing antibody pipelines. Pepscan also focuses on personalized medicine through the development of targeted vaccines, including neoantigen vaccines derived from tumor-specific antigens. Its capabilities support clients in both research and development and Good Manufacturing Practice (GMP) grade peptide production, making Pepscan a valuable partner in the biotechnology sector.

Aalto Bio Reagents specializes in the development and provision of biological raw materials and molecular controls for the in-vitro diagnostic and vaccine development sectors. The company offers a diverse portfolio that includes purified human proteins, monoclonal and polyclonal antibodies, as well as fungal, parasite, bacterial, and viral antigens. Additionally, Aalto Bio Reagents supplies disease-state human plasma and biospecimens, which are crucial for pharmaceutical companies in diagnosing and treating emerging diseases, including Chikungunya, Dengue, Zika, and COVID-19. With a focus on supporting the global in-vitro diagnostic industry and research organizations, Aalto Bio Reagents caters to multinational clients by providing high-quality biological materials essential for advancing healthcare solutions.

Vivitide is a manufacturer focused on producing peptides and polyclonal antibodies, catering to organizations involved in drug, vaccine, and diagnostic development. The company offers a range of services, including custom peptide synthesis and antibody packages, available for both small and large-scale industries. Its product offerings encompass peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, and resins, which are utilized in the treatment of various conditions such as cancer, diabetes, obesity, infections, and HIV. By providing high-quality and tailored solutions, Vivitide supports its clients in advancing their biomedical research and therapeutic applications.